Shell Asset Management CO Catalent, Inc. Transaction History

Shell Asset Management CO

$2.26 Billion
Q1 2024

A detailed history of Shell Asset Management CO transactions in Catalent, Inc. stock. As of the latest transaction made, Shell Asset Management CO holds 6,258 shares of CTLT stock, worth $365,592. This represents 0.02% of its overall portfolio holdings.

Number of Shares

6,258

Previous 10,950 42.85%

Holding current value

$365,592

Previous $492,000 28.25%

% of portfolio

0.02%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$42.56 - $59.82 $199,691 - $280,675	-4,692 Reduced 42.85%	6,258 $353,000
Q4 2023 Feb 14, 2024	SELL	$32.18 - $46.57 $278,389 - $402,877	-8,651 Reduced 44.14%	10,950 $492,000
Q3 2023 Nov 08, 2023	SELL	$44.2 - $50.2 $23,691 - $26,907	-536 Reduced 2.66%	19,601 $892,000
Q2 2023 Jul 28, 2023	SELL	$31.86 - $67.26 $148,818 - $314,171	-4,671 Reduced 18.83%	20,137 $873,000
Q1 2023 May 15, 2023	SELL	$45.44 - $74.26 $4,316 - $7,054	-95 Reduced 0.38%	24,808 $1.63 Million

Q4 2022 Feb 07, 2023	BUY	$41.39 - $81.0 $393,618 - $770,310	9,510 Added 61.78%	24,903 $1.12 Million
Q3 2022 Nov 14, 2022	SELL	$72.36 - $113.1 $226,486 - $354,003	-3,130 Reduced 16.9%	15,393 $1.11 Million
Q2 2022 Aug 09, 2022	BUY	$87.2 - $114.05 $683,473 - $893,923	7,838 Added 73.36%	18,523 $1.99 Million
Q1 2022 May 04, 2022	SELL	$94.19 - $124.49 $35,132 - $46,434	-373 Reduced 3.37%	10,685 $1.19 Million
Q4 2021 Feb 09, 2022	BUY	$119.57 - $139.07 $855,523 - $995,045	7,155 Added 183.32%	11,058 $1.42 Million
Q3 2021 Nov 04, 2021	BUY	$109.17 - $142.35 $56,222 - $73,310	515 Added 15.2%	3,903 $519,000
Q2 2021 Aug 12, 2021	BUY	$100.34 - $115.69 $259,980 - $299,752	2,591 Added 325.09%	3,388 $366,000
Q4 2020 Feb 16, 2021	BUY	$85.88 - $105.36 $21,727 - $26,656	253 Added 46.51%	797 $83,000
Q3 2020 Nov 13, 2020	SELL	$72.74 - $92.5 $482,193 - $613,182	-6,629 Reduced 92.42%	544 $47,000
Q2 2020 Aug 10, 2020	SELL	$48.02 - $79.04 $987,003 - $1.62 Million	-20,554 Reduced 74.13%	7,173 $526,000
Q1 2020 May 11, 2020	SELL	$36.95 - $62.95 $6,724 - $11,456	-182 Reduced 0.65%	27,727 $1.44 Million
Q4 2019 Feb 13, 2020	SELL	$47.06 - $56.64 $13,412 - $16,142	-285 Reduced 1.01%	27,909 $1.57 Million
Q3 2019 Nov 12, 2019	BUY	$47.45 - $58.05 $742,829 - $908,772	15,655 Added 124.85%	28,194 $1.34 Million
Q2 2019 Aug 12, 2019	BUY	$39.26 - $54.21 $492,281 - $679,739	12,539 New	12,539 $680,000

Others Institutions Holding CTLT

# of Institutions

484

Shares Held

171M

Call Options Held

865K

Put Options Held

687K

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.5B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.

Account

Shell Asset Management CO Catalent, Inc. Transaction History